Clinical Trial: Repurposing Valsartan May Protect Against Pulmonary Hypertension
Study Status: NOT_YET_RECRUITING
Recruit Status: NOT_YET_RECRUITING
Condition: Pulmonary Arterial Hypertension
Study Type: INTERVENTIONAL
Official Title: Repurposing Valsartan May Protect Against Pulmonary Hypertension
Brief Summary:
This is a Phase 2, single-center, randomized placebo controlled trial of valsartan (an angiotensin receptor blocker) in adults with pulmonary arterial hypertension.The study will evaluate the safety and clinical efficacy of a 24-week course of valsartan.
Read more